A Study of an Investigational Medication for Severe Primary Hyperparathyroidism or Parathyroid Cancer

Clinical trial NCT00037518 · COMPLETED

Trial details

NCT number: NCT00037518
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Hyperparathyroidism Parathyroid Neoplasms

Start date: 2001-04-01
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.